Monoclonal gammopathy of undetermined significance
1,652views
Monoclonal gammopathy of undetermined significance
SBL Exam 1
SBL Exam 1
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Anemia of chronic disease
Alpha-thalassemia
Beta-thalassemia
Iron deficiency anemia
Autoimmune hemolytic anemia
Paroxysmal nocturnal hemoglobinuria
Hereditary spherocytosis
Sickle cell disease (NORD)
Fanconi anemia
Megaloblastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Diamond-Blackfan anemia
Hemophilia
Thrombotic thrombocytopenic purpura
Hemolytic-uremic syndrome
Von Willebrand disease
Disseminated intravascular coagulation
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Langerhans cell histiocytosis
Multiple myeloma
Monoclonal gammopathy of undetermined significance
Waldenstrom macroglobulinemia
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Plasma cell disorders: Pathology review
Leukemias: Pathology review
Lymphomas: Pathology review
Myeloproliferative disorders: Pathology review
High Yield Notes
6 pages
Summary
Monoclonal gammopathy of undetermined significance (MGUS), is a condition in which there is a single paraprotein in blood without any evidence of other diseases or abnormal conditions.
MGUS is considered to be a "premalignant" condition and can eventually develop into multiple myeloma or a lymphoproliferative disorder. Treatment for MGUS is generally not necessary, as the condition is generally considered to be benign. However, regular monitoring is important.